Elizabeth Hackett - Concepedia

Author

Elizabeth Hackett

Columbia University

Also Known As

E HACKETT, E Hackett, E. Hackett, E.A. Hackett, ELIZABETH HACKETT, Elizabeth Hackett

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Columbia University New York Psychoanalytic Society and Institute New York State Psychiatric Institute Pfizer (United States)GlaxoSmithKline (United Kingdom)

About

Elizabeth Hackett is an author at Columbia University specializing in social sciences, psychopharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	848
2	Social Sciences	11	11	838
3	Arts	1	1	1.7K
4	Engineering	1	1	1.7K
5	Behavioral Sciences	1	1	1.7K

Elizabeth Hackett

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Separate but equal? A comparison of participants and data gathered via Amazon’s MTurk, social media, and face-to-face behavioral testing Krista Casler, Lydia Bickel, Elizabeth Hackett Computers in Human Behavior Behavioral SciencesSocial MediaEngineeringOnline ExperimentConsumer Research	2013	1.7K
Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia Mark Slifstein, Elsmarieke van de Giessen, Jared X. Van Snellenberg, JAMA Psychiatry	2015	386
Effect of sertraline on regional metabolic rate in patients with affective disorder Monte S. Buchsbaum, Joseph C. Wu, Benjamin V. Siegel, Biological Psychiatry SleepPsychiatryRegional Metabolic RatePsychotropic MedicationDepression	1997	305
The role of the D <sub>2</sub> dopamine receptor (D <sub>2</sub> R) in A <sub>2A</sub> adenosine receptor (A <sub>2A</sub> R)-mediated behavioral and cellular responses as revealed by A <sub>2A</sub> and D <sub>2</sub> receptor knockout mice Jiang‐Fan Chen, Rosario Moratalla, Francesco Impagnatiello, Proceedings of the National Academy of Sciences	2001	255
Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive Disorder Elizabeth Hackett, Arkady Rubin, Robert Wolkow, American Journal of Psychiatry	2002	139
Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. G Chouinard, Wayne K. Goodman, John H. Greist, PubMed Eighty-seven PatientsGlobal SeverityActive DrugPsychiatryAddiction	1990	136
Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride Lawrence S. Kegeles, Mark Slifstein, W. Gordon Frankle, Neuropsychopharmacology PsychiatryMedicinePsychopharmacologySchizophreniaNeuropharmacology	2008	132
Striatal and extrastriatal dopamine release measured with PET and [<sup>18</sup>F] fallypride Mark Slifstein, Lawrence S. Kegeles, Xiaoyan Xu, Synapse	2009	113
Sertraline treatment of panic disorder: results of a long-term study Mark Hyman Rapaport, Robert Wolkow, Arkady Rubin, Acta Psychiatrica Scandinavica	2001	69
Inactivation of Adenosine A2A Receptors Selectively Attenuates Amphetamine-Induced Behavioral Sensitization Jiang‐Fan Chen, Rosario Moratalla, Liqun Yu, Neuropsychopharmacology Behavioral NeuroscienceAddictionMedicineBehavioral PharmacologyPhysiology	2003	69

Page 1